BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15567312)

  • 21. Prediction of Optimum Combination of Eudragit RS/Eudragit RL/Ethyl Cellulose Polymeric Free Films Based on Experimental Design for Using as a Coating System for Sustained Release Theophylline Pellets.
    Akhgari A; Tavakol A
    Adv Pharm Bull; 2016 Jun; 6(2):219-25. PubMed ID: 27478784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
    Bhattacharjya S; Wurster DE
    AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphology and surface properties of blends of Eudragit RS with different poly(ethylene glycol)s.
    Lovrecich M; Rubessa F
    Pharm Dev Technol; 1998 Feb; 3(1):123-9. PubMed ID: 9532607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of relative humidity on the mechanical and drug release properties of theophylline pellets coated with an acrylic polymer containing methylparaben as a non-traditional plasticizer.
    Wu C; McGinity JW
    Eur J Pharm Biopharm; 2000 Sep; 50(2):277-84. PubMed ID: 10962239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T; McGinity JW
    Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings.
    Wagner KG; Gruetzmann R
    AAPS J; 2005 Oct; 7(3):E668-77. PubMed ID: 16353943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions.
    Omari DM; Sallam A; Abd-Elbary A; El-Samaligy M
    Int J Pharm; 2004 Apr; 274(1-2):85-96. PubMed ID: 15072785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
    Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
    Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic analysis of drug release from theophylline pellets coated by films containing pectin, chitosan and Eudragit RS.
    Ghaffari A; Avadi MR; Moghimi HR; Oskoui M; Bayati K; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2008 Apr; 34(4):390-402. PubMed ID: 18401781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
    Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
    J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.
    Bodmeier R; Paeratakul O
    Pharm Res; 1994 Jun; 11(6):882-8. PubMed ID: 7937530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of acrylic esters and methacyrlic esters on flotation of pellets and release rate of verapamil hydrochloride.
    Lunio R; Sawicki W
    Acta Pol Pharm; 2006; 63(1):69-74. PubMed ID: 17515332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dry powder coating of pellets with micronized Eudragit RS for extended drug release.
    Pearnchob N; Bodmeier R
    Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets.
    Muskó Z; Pintye-Hódi K; Gáspár R; Pintye J; Szabó-Révész P; Eros I; Falkay G
    Eur J Pharm Biopharm; 2001 Mar; 51(2):143-6. PubMed ID: 11226821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.